-
101por Prindiville, Sheila A., Sarosy, Gisele A., Loose, David, Ciolino, Henry, Doroshow, James H.“…Here, we highlight an analysis using information from the National Cancer Institute (NCI) Clinical Trials Reporting Program database to describe enrollment patterns to interventional cancer treatment trials at NCI-Designated Cancer Centers during the pandemic. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
102por Westergaard, Sarah A., Rupji, Manali, Franklin, Lauren E., Behera, Madhusmita, Ramalingam, Suresh S., Higgins, Kristin A.“…INTRODUCTION: Tobacco cessation is a critical but challenging intervention for cancer patients. Our National Cancer Institute‐designated Comprehensive Cancer Center instituted a tobacco cessation program in 2019. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
103por Thanabalasingam, Susan J., Ranawaka, Sarith S., Gunarathna, Sathika S.C., Yathev, Bala, Booth, Christopher M., Seneviratne, Sanjeewa, Gunasekera, Sanjeeva, Wijeratne, Don Thiwanka“…METHODS: A telephone-based survey was conducted in the three official languages (Sinhala, Tamil, or English) among adult women (older than 18 years) who had been treated for breast cancer within 6-12 months of diagnosis at the National Cancer Institute of Sri Lanka. The European Organisation for Research and Treatment of Cancer Satisfaction with Cancer Care core questionnaire was adapted to assess three main domains (physicians, allied health care professionals, and the organization). …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
104“…INTRODUCTION: In 2002, the Cancer Information Service (CIS) of the National Cancer Institute added to its toll-free telephone number 2 choices of media for access to cancer information specialists: e-mail and a proprietary online instant messaging service called LiveHelp. …”
Enlace del recurso
Enlace del recurso
Texto -
105por Hsu, Elizabeth R., Williams, Duane E., DiJoseph, Leo G., Schnell, Joshua D., Finstad, Samantha L., Lee, Jerry S. H., Greenspan, Emily J., Corrigan, James G.“…We demonstrate that two types of applicants were attracted by the PQs at rates greater than or on par with the general National Cancer Institute applicant pool: those with clinical degrees and new investigators. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
106por Merola, Roberta, Tomao, Luigi, Antenucci, Anna, Sperduti, Isabella, Sentinelli, Steno, Masi, Serena, Mandoj, Chiara, Orlandi, Giulia, Papalia, Rocco, Guaglianone, Salvatore, Costantini, Manuela, Cusumano, Giuseppe, Cigliana, Giovanni, Ascenzi, Paolo, Gallucci, Michele, Conti, Laura“…METHODS: 407 Italian men, with two or more PCa risk factors and at least a previous negative biopsy, entering the Urology Unit of Regina Elena National Cancer Institute, were tested for PCA3, total PSA (tPSA) and free PSA (fPSA and f/tPSA) tests. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
107por Ruiz, Eloy, Rojas Rojas, Teresa, Berrospi, Francisco, Chávez, Ivan, Luque, Carlos, Cano, Luis, Doimi, Franco, Pineau, Pascal, Deharo, Eric, Bertani, Stéphane“…We conducted a retrospective cohort study of 253 hepatocellular carcinoma patients that underwent a curative hepatectomy between 1991 and 2011 at the National Cancer Institute of Peru. The median age of the cohort was 36 years, and merely 15.4% of the patients displayed cirrhosis. …”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
108por Schoen, Martin W, Basch, Ethan, Hudson, Lori L, Chung, Arlene E, Mendoza, Tito R, Mitchell, Sandra A, St. Germain, Diane, Baumgartner, Paul, Sit, Laura, Rogak, Lauren J, Shouery, Marwan, Shalley, Eve, Reeve, Bryce B, Fawzy, Maria R, Bhavsar, Nrupen A, Cleeland, Charles, Schrag, Deborah, Dueck, Amylou C, Abernethy, Amy P“…BACKGROUND: The US National Cancer Institute (NCI) developed software to gather symptomatic adverse events directly from patients participating in clinical trials. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
109por Sirirungreung, Anupong, Buasom, Rangsiya, Jiraphongsa, Chuleeporn, Sangrajrang, Suleeporn“…This study aimed to assess the coding completeness and reliability of the National Cancer Institute (NCI) hospital-based cancer registry, Thailand. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
110por Cho, Juhee, Yoon, Junghee, Kim, Youngha, Oh, Dongryul, Kim, Seok Jin, Ahn, Jinseok, Suh, Gee Young, Nam, Seok Jin, Mitchell, Sandra A.“…PURPOSE: The aim of this study was to translate and linguistically validate a Korean-language version of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
111“…We aimed to identify the educational needs and clinical trial participation barriers at National Cancer Institute Community Oncology Research Program (NCORP) Children’s Oncology Group (COG) sites to improve the quality of site investigator engagement. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
112por Doykos, Patricia M., Chen, Moon S., Watson, Karriem, Henderson, Vida, Baskin, Monica L., Downer, Sarah, Smith, Lauren A., Bhavaraju, Neeraja, Dina, Samantha, Lathan, Christopher S.“…In addition to its support of a joint research agenda for health disparities in 2017, the National Cancer Institute (NCI) has demonstrated its commitment to addressing health inequities with its 2012 requirement for cancer centers to define and address the needs of a local “catchment area” and the 2016 mandate for Community Outreach and Engagement (COE). …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
113por Suranadee, Y. W. S., Dissanayake, Y., Dissanayake, B. M. B. T., Jyalatharachchi, H. R., Gamage, S., Gunasekara, S. P.Enlace del recurso
Publicado 2022
Enlace del recurso
Online Artículo Texto -
114por Mascaro, Jennifer S., Catic, Almira, Srivastava, Meha, Diller, Maggie, Rana, Shaheen, Escoffery, Cam, Master, VirajEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
115por Cofer, Jennifer, Hurst, Alex N., Winter, Tiffany, Moreno, Mark, Cinciripini, Paul M., Walsh, Michael T, Tektiridis, Jennifer, Hawk, ErnestEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
116por Kim, Joseph W., McKay, Rana R., Radke, Marc R., Zhao, Shilin, Taplin, Mary-Ellen, Davis, Nancy B., Monk, Paul, Appleman, Leonard J., Lara, Primo N., Vaishampayan, Ulka N., Zhang, Jingsong, Paul, Asit K., Bubley, Glenn, Van Allen, Eliezer M., Unlu, Serhan, Huang, Ying, Loda, Massimo, Shapiro, Geoffrey I., Glazer, Peter M., LoRusso, Patricia M., Ivy, S. Percy, Shyr, Yu, Swisher, Elizabeth M., Petrylak, Daniel P.Enlace del recurso
Publicado 2023
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
117por Buckstein, R., Meyer, R.M., Seymour, L., Biagi, J., MacKay, H., Laurie, S., Eisenhauer, E.“…In the present article, we discuss the biologic and clinical rationales that have recently led the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group to initiate four phase ii trials testing this agent in the following four different tumour types: relapsed diffuse large cell lymphoma, malignant pleural mesothelioma, locally advanced or metastatic cervical cancer and recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.…”
Publicado 2007
Enlace del recurso
Enlace del recurso
Texto -
118por Courneya, K.S., Booth, C.M., Gill, S., O’Brien, P., Vardy, J., Friedenreich, C.M., Au, H.J., Brundage, M.D., Tu, D., Dhillon, H., Meyer, R.M.“…PURPOSE: The co.21 Colon Health and Life-Long Exercise Change (challenge) trial undertaken by the National Cancer Institute of Canada Clinical Trials Group (ncic ctg) is designed to determine the effects of a structured pa intervention on outcomes for survivors of high-risk stage ii or iii colon cancer who have completed adjuvant therapy within the previous 2–6 months. …”
Publicado 2008
Enlace del recurso
Enlace del recurso
Texto -
119por Arrieta, Oscar, Quintana-Carrillo, Roger Humberto, Ahumada-Curiel, Gabriel, Corona-Cruz, Jose Francisco, Correa-Acevedo, Elma, Zinser-Sierra, Juan, de la Mata-Moya, Dolores, Mohar-Betancourt, Alejandro, Morales-Oyarvide, Vicente, Reynales-Shigematsu, Luz Myriam“…The aim of this study was to assess the direct medical costs attributable to smoking incurred by lung cancer patients treated at the National Cancer Institute of Mexico (INCan). METHODS: The study was conducted at INCan in 2009. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
120por Dimond, Eileen P, St. Germain, Diane, Nacpil, Lianne M, Zaren, Howard A, Swanson, Sandra M, Minnick, Christopher, Carrigan, Angela, Denicoff, Andrea M, Igo, Kathleen E, Acoba, Jared D, Gonzalez, Maria M, McCaskill-Stevens, Worta“…In addition to the National Cancer Institute’s Community Clinical and Minority-Based Oncology Programs established in 1983, and 1991 respectively, the National Cancer Institute established the National Cancer Institute Community Cancer Centers Program in 2007 with an aim of enhancing access to high-quality cancer care and clinical research in the community setting where most cancer patients receive their treatment. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto